Review: taking Lovenox and Flagyl together


Summary

Drug interactions are reported among people who take Lovenox and Flagyl together. This review analyzes the effectiveness and drug interactions between Lovenox and Flagyl. It is created by eHealthMe based on reports of 1,069 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Lovenox and Flagyl >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Lovenox

Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. (latest outcomes from Lovenox 19,189 users)

Flagyl

Flagyl has active ingredients of metronidazole. It is often used in crohn's disease. (latest outcomes from Flagyl 10,347 users)

On Jul, 26, 2016

1,069 people who take Lovenox, Flagyl are studied.


Number of reports submitted per year:

Lovenox and Flagyl drug interactions.

Drug effectiveness over time:

Lovenox:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Flagyl:
  • < 1 month: 0.0% - (0 of 4 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Lovenox:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 2 people)
Flagyl:
  • female: 0.0% - (0 of 2 people)
  • male: 0.0% - (0 of 2 people)

Drug effectiveness by age:

Lovenox:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 0.0% - (0 of 0 people)
Flagyl:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • renal failure acute
  • febrile neutropenia
  • thrombocytopenia
  • pancytopenia
  • lymphopenia
  • cholestasis
  • gamma-glutamyltransferase increased
  • haematuria
  • oliguria
  • diarrhoea
1 - 6 months:
  • pulmonary embolism
  • abscess
  • diverticular perforation
  • abdominal pain
  • contusion
  • deep vein thrombosis
  • groin pain
  • inflammation
  • oedema peripheral
  • neutropenia
6 - 12 months:
  • febrile neutropenia
  • leukopenia
  • pyrexia
2 - 5 years:
  • cardiogenic shock
  • dermatitis exfoliative
  • injury
  • pain
  • psychiatric symptom
  • renal failure
not specified:
  • pain
  • anxiety
  • injury
  • asthenia
  • pyrexia
  • anaemia
  • anhedonia
  • osteonecrosis of jaw
  • osteoarthritis
  • depression

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • injury
  • asthenia
  • osteonecrosis of jaw
  • anaemia
  • pyrexia
  • depression
  • anhedonia
  • urinary tract infection
male:
  • pain
  • anxiety
  • thrombocytopenia
  • injury
  • pyrexia
  • anaemia
  • anhedonia
  • hypotension
  • nausea
  • dyspnoea

Most common drug interactions by age *:

0-1:
  • abdominal distension
  • haematochezia
  • intestinal functional disorder
  • necrotising colitis
  • heart disease congenital
2-9:
  • depressed level of consciousness
  • drug ineffective
  • cholestasis
  • pancreatitis
  • pruritus generalised
  • rash generalised
  • rash morbilliform
  • abdominal pain
  • abnormal behaviour
  • acidosis
10-19:
  • neutropenia
  • injection site pain
  • agranulocytosis
  • cerebral artery thrombosis
  • international normalised ratio increased
  • intestinal resection
  • liver abscess
  • pancreatitis
  • pouchitis
  • pyrexia
20-29:
  • renal failure acute
  • propofol infusion syndrome
  • rhabdomyolysis
  • cholecystitis
  • pain
  • injury
  • lymphadenopathy
  • mass
  • pulmonary embolism
  • vomiting
30-39:
  • asthenia
  • pain
  • anxiety
  • muscle spasms
  • type 2 diabetes mellitus
  • alanine aminotransferase increased
  • anhedonia
  • dyskinesia
  • dysphagia
  • injury
40-49:
  • pain
  • anxiety
  • pyrexia
  • anaemia
  • pain in jaw
  • nausea
  • sinusitis
  • dyspnoea
  • injury
  • anhedonia
50-59:
  • pain
  • anxiety
  • injury
  • anaemia
  • anhedonia
  • emphysema
  • atelectasis
  • intervertebral disc protrusion
  • oedema peripheral
  • osteoarthritis
60+:
  • anxiety
  • pain
  • asthenia
  • injury
  • anaemia
  • diarrhoea
  • osteoarthritis
  • pyrexia
  • osteonecrosis of jaw
  • bone disorder

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Lovenox and Flagyl?

Can you answer these questions?

More questions for: Lovenox, Flagyl

You may be interested in these reviews

More reviews for: Lovenox, Flagyl

On eHealthMe, Lovenox (enoxaparin sodium) is often used to treat deep venous thrombosis. Flagyl (metronidazole) is often used to treat crohn's disease. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.